Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-07-15

Clinical Trial Update: Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome [Phase 3]

View source ↗

Summary

Phase 3 safety and efficacy study of teduglutide in subjects with Short Bowel Syndrome completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Teduglutide (teduglutide)

Snippet

Sponsor: Shire | Conditions: Short Bowel Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2013-07-15